Canada based drug firm Apotex Inc is recalling 91,962 bottles of Losartan potassium tablets in the US that were made by the company's Indian arm Apotex Research Pvt Ltd.
As per information on the US Food and Drug Administration (USFDA) website, Apotex Inc is recalling the bottles of high blood pressure treatment tablets due to "failed content uniformity specifications".
The drugs in various strengths including 25 mg, 50mg and 100 mg, were manufactured for Apotex Inc by Bengaluru based Apotex Research.
Also Read
The recall was initiated by the company on May 29 this year.
It has been classified as a 'Class-II recall' which FDA defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
An email query sent to the company remained unanswered.
